A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C
- 1 November 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 39 (5) , 843-849
- https://doi.org/10.1016/s0168-8278(03)00391-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Biochemical and Viral Response to Consensus Interferon (Cifn) Therapy in Chronic Hepatitis C Patients: Effect of Baseline Viral ConcentrationAmerican Journal of Gastroenterology, 1999
- Efficacy of interferon alfacon-1 daily induction therapy followed by three-times weekly therapy in patients with chronic hepatitis C virus infection with high and low viral titersHepatology Research, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Re-treatment of chronic hepatitis C with consensus interferonHepatology, 1998
- Treatment of Chronic Hepatitis C Virus Infection with Recombinant Consensus InterferonJournal of Interferon & Cytokine Research, 1998
- National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis CHepatology, 1997
- Therapy of hepatitis C: Consensus interferon trialsHepatology, 1997
- Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trialHepatology, 1997
- The Biologic Activity and Molecular Characterization of a Novel Synthetic Interferon-Alpha Species, Consensus InterferonJournal of Interferon & Cytokine Research, 1996